Replies to post #4611 on Biotech Values

[DewDiligence]

>> my amateurish observation tells me 33% to 26% is not the way to go, especially when compared to Lucentis 45%,34%. Is there more to look at than this? Have you lost confidence in GENR to come through? <<

biotplaya: I want to see compelling data that replicate or nearly replicate the visual-acuity outcomes of the phase-1/2 study in Mexico. Regards, Dew